Abstract
We demonstrate how genetic testing enabled a molecular prenatal diagnosis of congenital long QT syndrome in a 20-week fetus presenting with fetal bradycardia in the setting of maternal β-blocker therapy. Before prenatal testing, strategic genotyping, based on a family history of a near drowning, was performed on a 3-generation family with clinically diagnosed long QT syndrome in which the affected mother was pregnant.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 788-791 |
| Number of pages | 4 |
| Journal | American Journal of Cardiology |
| Volume | 93 |
| Issue number | 6 |
| DOIs | |
| State | Published - Mar 15 2004 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Prenatal molecular genetic diagnosis of congenital long QT syndrome by strategic genotyping'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS